Neuronal nitric oxide synthase polymorphisms in obsessive-compulsive disorder

References

• Pauls DL, Abramovitch A, Rauch SL, Geller DA. Obsessive-compulsive disorder: An integrative genetic and neurobiological perspective. Nat Rev Neurosci 2014;15:410–24.
   PubMed Web of Science ®Google Scholar
• Cengiz M, Okutan SN, Bayoglu B, Sakalli Kani A, Bayar R, Kocabasoglu N. Genetic polymorphism of the serotonin transporter gene, SLC6A4 rs16965628, is associated with obsessive compulsive disorder. Genet Test Mol Biomarkers 2015;19:228–34.
   PubMed Web of Science ®Google Scholar
• Meira-Lima I, Shavitt RG, Miguita K, Ikenaga E, Miguel EC, Vallada H. Association analysis of the catechol-o-methyltransferase (COMT), serotonin transporter (5-HTT) and serotonin 2A receptor (5HT2A) gene polymorphisms with obsessive-compulsive disorder. Genes Brain Behav 2004;3:75–9.
   PubMed Web of Science ®Google Scholar
• Arnold PD, Rosenberg DR, Mundo E, Tharmalingam S, Kennedy JL, Richter MA. Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obsessive-compulsive disorder: A preliminary study. Psychopharmacology (Berl) 2004;174:530–8.
   PubMed Web of Science ®Google Scholar
• Millet B, Chabane N, Delorme R, Leboyer M, Leroy S, Poirier MF, et al. Association between the dopamine receptor D4 (DRD4) gene and obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet 2003;116B:55–9.
   PubMed Web of Science ®Google Scholar
• Zai G, Bezchlibnyk YB, Richter MA, Arnold P, Burroughs E, Barr CL, Kennedy JL. Myelin oligodendrocyte glycoprotein (MOG) gene is associated with obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet 2004;129B:64–8.
   PubMed Web of Science ®Google Scholar
• Bokor G, Anderson PD. Obsessive-compulsive disorder. J Pharm Pract 2014;27:116–30.
   PubMedGoogle Scholar
• Shirani Bidabadi S, Mehryar A. Music therapy as an adjunct to standard treatment for obsessive compulsive disorder and co-morbid anxiety and depression: A randomized clinical trial. J Affect Disord 2015;184:13–7.
   PubMed Web of Science ®Google Scholar
• Hu Y, Zhu DY. Hippocampus and nitric oxide. Vitam Horm 2014;96:127–60.
   PubMed Web of Science ®Google Scholar
• Dhir A, Kulkarni SK. Nitric oxide and major depression. Nitric Oxide 2011;24:125–31.
   PubMed Web of Science ®Google Scholar
• Joca SR, Ferreira FR, Guimarães FS. Modulation of stress consequences by hippocampal monoaminergic, glutamatergic and nitrergic neurotransmitter systems. Stress 2007;10:227–49.
   PubMed Web of Science ®Google Scholar
• Atmaca M, Tezcan E, Kuloglu M, Ustundag B. Plasma nitrate values in patients with obsessive-compulsive disorder. Psychiatry Clin Neurosci 2005;59:621–3.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Assosiation American Psychiatric Assosiation Diagnostic and Statistical Manual of Mental Disorder. 4th ed. Washington DC: American Psychiatric Press, 1994.
   Google Scholar
• First MB, Spitzer RL, Williams JBW, Structured clinical interview for DSM-IV CID. Washington DC: American Psychiatric Association, 1997.
   Google Scholar
• Ozkurkcugil A, Aydemir O, Yildiz M, Esen Danaci A, Koroglu E. Adaptation of the structured clinical interviews for DSM-IV Axis I disorders to Turkish and reliability study. Drug Treat J 1999;12:233–6.
   Google Scholar
• Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, et al. The yale-brown obsessive compulsive scale. II. Validity. Arch Gen Psychiatry 1989; 46:1012–6.
   PubMed Web of Science ®Google Scholar
• Tek C, Ulug B, Rezaki BG, Tanriverdi N, Mercan S, Demir B, et al. Yale-Brown obsessive compulsive scale and US National Institute of mental health Global obsessive compulsive scale in Turkish: reliability and validity. Acta Psychiatrica Scandinavica 1995; 91:410–3.
   PubMed Web of Science ®Google Scholar
• Miller IW, Bishop S, Norman WH, Maddever H. The modified Hamilton rating scale for depression: reliability and validity. Psychiatry Res 1985;14:131–42.
   PubMed Web of Science ®Google Scholar
• Akdemir S, Orsel I, Dag H, Turkcapar N, Iscan H. Validity, reliability and clinical use of Hamilton rating scale for depression (HRSD). J Psychiatry Psychol Psychopharmacol 1996;4:251–9.
   Google Scholar
• Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959;32:50–5.
   PubMed Web of Science ®Google Scholar
• Yazici MK, Demir B, Tanriverdi N, Karaaoaoglu E, Yolac P. Hamilton Anxiety Rating Scale (HAM-A), a study of interpreter reliability and validity. Turkish J Psychiatry 1998;9:114–7.
   Google Scholar
• Gencer M, Dasdemir S, Cakmakoglu B, Cetinkaya Y, Varlibas F, Tireli H, et al. DNA repair genes in Parkinson's disease. Genet Test Mol Biomarkers 2012;16:504–7.
   PubMed Web of Science ®Google Scholar
• Mathis MA, Alvarenga PD, Funaro G, Torresan RC, Moraes I, Torres AR, et al. Gender differences in obsessive-compulsive disorder: a literature review. Rev Bras Psiquiatr 2011;33:390–9.
   PubMed Web of Science ®Google Scholar
• Cheah JH, Kim SF, Hester LD, Clancy KW, Patterson SE, 3rd, Papadopoulos V, Snyder SH. NMDA receptor-nitric oxide transmission mediates neuronal iron homeostasis via the GTPase Dexras1. Neuron 2006;51:431–40.
   PubMed Web of Science ®Google Scholar
• Delorme R, Betancur C, Scheid I, Anckarsäter H, Chaste P, Jamain S, et al. Mutation screening of NOS1AP gene in a large sample of psychiatric patients and controls. BMC Med Genet 2010;11:108.
   PubMed Web of Science ®Google Scholar
• Freudenberg F, Alttoa A, Reif A. Neuronal nitric oxide synthase (NOS1) and its adaptor, NOS1AP, as a genetic risk factors for psychiatric disorders. Genes Brain Behav 2015;14:46–63.
   PubMed Web of Science ®Google Scholar
• Alaşehirli B, Akçalı A, Demiryürek AT, Özel A, Erdal ME, Neyal M. Lack of association between the C276T polymorphism of the neuronal nitric oxide synthase gene and migraine. Int J Neurosci 2013;123:50–4.
   PubMed Web of Science ®Google Scholar
• Venturelli E, Villa C, Scarpini E, Fenoglio C, Guidi I, Lovati C, et al. Neuronal nitric oxide synthase C276T polymorphism increases the risk for frontotemporal lobar degeneration. Eur J Neurol 2008;15:77–81.
   PubMed Web of Science ®Google Scholar
• Galimberti D, Venturelli E, Gatti A, Lovati C, Fenoglio C, Mariani C, et al. Association of neuronal nitric oxide synthase C276T polymorphism with Alzheimer's disease. J Neurol 2005;252:985–6.
   PubMed Web of Science ®Google Scholar
• Levecque C, Elbaz A, Clavel J, Richard F, Vidal JS, Amouyel P, et al. Association between Parkinson's disease and polymorphisms in the nNOS and iNOS genes in a community-based case-control study. Hum Mol Genet 2003;12:79–86.
   PubMed Web of Science ®Google Scholar
• Saur JM, Vanderwinden B, Seidler RM, Schmid MH, De Laet HD. Allescher Single-nucleotide promoter polymorphism alters transcription of neuronal nitric oxide synthase exon 1c in infantile hypertrophic pyloric stenosis. Proc Natl Acad Sci USA 2004;101:1662–7.
   PubMed Web of Science ®Google Scholar
• Kishimoto J, Spurr N, Liao M, Lizhi L, Emson P, Xu W. Localization of brain nitric oxide synthase (NOS) to human chromosome 12. Genomics 1992;14:802–4.
   PubMed Web of Science ®Google Scholar
• Grasemann H, Yandava CN, Drazen JM. Neuronal NO synthase (NOS1) is a major candidate gene for asthma. Clin Exp Allergy 1999;29:39–41.
   PubMed Web of Science ®Google Scholar